Delcath Systems, Inc.
(NASDAQ : DCTH)

( )
DCTH After-Hours: () as of PM
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield

Message Boards

...

News

...
Health Technology » Medical Specialties

Company Profile

Delcath Systems, Inc. is a pharmaceutical and medical device company, which focuses on oncology and liver cancer therapy. It develops and commercializes Melphalan Hydrochloride for Injection, which is a proprietary product for use with the Delcath Hepatic Delivery System. It is designed to administer concentrated regional chemotherapy to the liver. The company was founded on August 5, 1988 and is headquartered in New York, NY.